First published · Last updated
Non-clinical safety evaluation of coenzyme I (NAD⁺): A GLP-compliant systematic study
Journal article published by Elsevier reporting a GLP-compliant systematic non-clinical safety evaluation of coenzyme I (NAD⁺), published 2026-11-01. The supplied excerpt contains only publisher and content-type information beyond the title.
Categories: science-and-space, public-health
Generated scores
Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.
- Confidence
- 6/10
- Geographic reach
- 1/10
- Global importance
- 2/10
- Impact magnitude
- 3/10
- Positivity
- 6/10
- Urgency
- 2/10
Why it matters
The study reports a systematic safety evaluation of NAD⁺ that is relevant to research and development around this compound.

